What are the best oral antibiotics for Haemophilus influenzae (H. flu) infections?

From the Guidelines

For Haemophilus influenzae infections, amoxicillin-clavulanate is the preferred oral antibiotic choice, as it effectively treats beta-lactamase producing strains, with a recommended dose of 45 mg/kg/day divided twice daily for children or 875/125 mg twice daily for adults for 7-10 days. This recommendation is based on the most recent and highest quality study available, which emphasizes the importance of considering the increasing prevalence of beta-lactamase producing strains of H. influenzae 1. Alternative options include second or third-generation cephalosporins such as cefuroxime or cefpodoxime, which have been shown to be effective against H. influenzae in various studies 1. For patients with penicillin allergies, trimethoprim-sulfamethoxazole or fluoroquinolones like levofloxacin can be effective alternatives 1.

Key Considerations

• The choice of antibiotic should be based on the severity of the infection, with more severe infections requiring broader coverage and potentially longer treatment durations 1.
• The increasing prevalence of beta-lactamase producing strains of H. influenzae highlights the importance of using antibiotics that are effective against these resistant strains, such as amoxicillin-clavulanate 1.
• Treatment duration typically ranges from 7-14 days, depending on the site and severity of infection, with longer courses needed for more serious infections like pneumonia or sinusitis 1.

Antibiotic Options

• Amoxicillin-clavulanate: 45 mg/kg/day divided twice daily for children or 875/125 mg twice daily for adults for 7-10 days 1.
• Second or third-generation cephalosporins: such as cefuroxime or cefpodoxime, which have been shown to be effective against H. influenzae in various studies 1.
• Trimethoprim-sulfamethoxazole or fluoroquinolones: for patients with penicillin allergies, these alternatives can be effective 1.

From the FDA Drug Label

Amoxicillin for oral suspension is indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of ... Haemophilus influenzae. Amoxicillin and clavulanate potassium tablets USP is a combination penicillin-class antibacterial and beta-lactamase inhibitor indicated in the treatment of infections due to susceptible isolates of the designated bacteria in the conditions listed below*: 1.1 Lower Respiratory Tract Infections – caused by beta-lactamase–producing isolates of Haemophilus influenzae and Moraxella catarrhalis.

The best oral antibiotics for Haemophilus influenzae (H. flu) infections are:

• Amoxicillin for β-lactamase–negative isolates 2
• Amoxicillin and clavulanate potassium for β-lactamase–producing isolates 3

From the Research

Antibiotic Options for Haemophilus influenzae Infections

The following oral antibiotics have been studied for their effectiveness against Haemophilus influenzae infections:

• Amoxicillin-clavulanate: This combination has been shown to be effective against H. influenzae, including strains with reduced susceptibility to ampicillin 4, 5, 6, 7.
• Levofloxacin: This fluoroquinolone has been demonstrated to have pharmacodynamic activity against H. influenzae, including strains with decreased susceptibility to amoxicillin/clavulanic acid 8.
• Cefpodoxime: This third-generation cephalosporin has been shown to be active against H. influenzae, with a low percentage of isolates exhibiting reduced susceptibility 4, 5.
• Azithromycin: This macrolide has been studied for its effectiveness against H. influenzae, although its activity may be lower than that of other antibiotics, such as levofloxacin 8.

Resistance Patterns

H. influenzae isolates have been found to exhibit resistance to various antibiotics, including:

• Ampicillin: Resistance to ampicillin is common, with 28.1% of isolates exhibiting reduced susceptibility in one study 4.
• Chloramphenicol: Resistance to chloramphenicol has been reported, with 42% of isolates exhibiting resistance in one study 7.
• Trimethoprim-sulfamethoxazole: Resistance to this combination has been reported, with 44% of isolates exhibiting resistance in one study 7.

Treatment Recommendations

Based on the available evidence, the following treatment recommendations can be made:

• Amoxicillin-clavulanate is a suitable option for the treatment of H. influenzae infections, including those caused by strains with reduced susceptibility to ampicillin 4, 5, 6, 7.
• Levofloxacin may be considered as an alternative option for the treatment of H. influenzae infections, particularly in cases where the isolate exhibits decreased susceptibility to amoxicillin/clavulanic acid 8.
• Cefpodoxime and azithromycin may also be considered as treatment options, although their activity may be lower than that of amoxicillin-clavulanate and levofloxacin 4, 5, 8.